Additional Information
Market: TSX
Sector: General Mining
EPIC: TSXC
Latest Price: 14,960.50  (0,00%)
52-week High: 0.00
52-week Low: 0.00
1 year chart
1 day chart

Permira takes Atrium Innovations private for $1.1 billion

29th Nov 2013, 12:20 pm by Anwar Ali
Including the assumption of debt, the transaction values Atrium at $1.1 billion. Including the assumption of debt, the transaction values Atrium at $1.1 billion.

Shares of Atrium Innovations (TSE:ATB) spiked to their highest level in six years after Permira funds agreed to buy the company for $24 per share.

Permira, a European private equity firm, will become the majority owner of the natural supplement manufacturer with the cash purchase of three-quarters of all outstanding shares, while two Quebec pension funds, Fonds de solidarité and Caisse de dépôt et placement du Québec, will split the remaining stake. Including the assumption of debt, the transaction values Atrium at $1.1 billion.

The offer is a 27% premium to the 30-day volume weighted average price and a 23% premium on Thursday's close.
Atrium said it will maintain its head office in Québec and complete the expansion of its manufacturing facility in the province. No jobs will be lost as a result of the transaction.

The company's board has recommended that shareholders accept the offer.

“Atrium intends to continue to pursue its growth strategy both organically and through acquisitions. The Permira funds’, the Fonds’ and CDPQ’s resources provide us the ability to accelerate our growth with the financial ability to expand globally," said Atrium president and chief executive officer Pierre Fitzgibbon in a statement.

According to terms of the agreement, Atrium has a 45-day period, beginning today, during which it can solicit other deals which, if materialize, Permira will have the right to match even after the go-shop period elapses. If Atrium agrees to another proposal during the go-shop period, it will have to pay Permira $13.5 million. The break fee rises to $23.1 million under undisclosed circumstances.

Prior to the announcement of this transaction, Atrium's market value had grown two-thirds this year.

No investment advice


Proactive Investors North America Inc, trades as "Proactiveinvestors USA & Canada".


You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is suitable or advisable for any specific person. You further understand that none of the information providers or their affiliates will advise you personally concerning the nature, potential, advisability, value or suitability of any particular security, portfolio of securities, transaction, investment strategy, or other matter.


You understand that the Site may contain opinions from time to time with regard to securities mentioned in other products, including company related products, and that those opinions may be different from those obtained by using another product related to the Company. You understand and agree that contributors may write about securities in which they or their firms have a position, and that they may trade such securities for their own account. In cases where the position is held at the time of publication and such position is known to the Company, appropriate disclosure is made. However, you understand and agree that at the time of any transaction that you make, one or more contributors may have a position in the securities written about. You understand that price and other data is supplied by sources believed to be reliable, that the calculations herein are made using such data, and that neither such data nor such calculations are guaranteed by these sources, the Company, the information providers or any other person or entity, and may not be complete or accurate.


From time to time, reference may be made in our marketing materials to prior articles and opinions we have published. These references may be selective, may reference only a portion of an article or recommendation, and are likely not to be current. As markets change continuously, previously published information and data may not be current and should not be relied upon.


You understand that we may be providing advertising and/or marketing services to companies mentioned on the site. A full list of companies that are paying for services from us, or our affiliated companies in the UK and Australia can be viewed here